Clinical trial
Upper GI Handling of Branded vs. Generic Alendronate
NCT00400530 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00400530 |
|---|---|
| Title | Upper GI Handling of Branded vs. Generic Alendronate |
| Official title | A Randomized, Single-Blind Study to Evaluate Upper Gastrointestinal Handling of Branded Versus Generic Alendronate Tablets |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | MK0217, alendronate sodium / Duration of Treatment: 1 Month, Comparator: Alendronate-Teva / Duration of Treatment: 1 Month |
| Enrollment | 25 |
| Start date | Dec 1, 2005 |
| First posted | Nov 17, 2006 |
| Last update posted | Nov 17, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: